Click Holdings Limited (NASDAQ:CLIK) Short Interest Update

Click Holdings Limited (NASDAQ:CLIK) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totaling 3,446 shares, an increase of 490.1% from the December 31st total of 584 shares. Based on an average daily trading volume, of 9,700 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.3% of the company’s shares are sold short. Currently, 0.3% of the company’s shares are sold short. Based on an average daily trading volume, of 9,700 shares, the days-to-cover ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Click Stock Down 3.8%

Shares of NASDAQ CLIK opened at $4.69 on Friday. Click has a 1 year low of $4.32 and a 1 year high of $102.90. The stock’s 50-day simple moving average is $5.50 and its 200-day simple moving average is $7.88.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.